ADHD medication may mitigate the increased risk of all-cause mortality that has been observed with ADHD, according to a systematic review and meta-analysis. Read more on MIMS buff.ly/RvClnrW

This week's #DrugShortages ➡️ Cilostazol 50mg and 100mg tablets: various For more information, see the MIMS Drug Shortages tracker buff.ly/Dy2atMk

A lower dose version of the nasal adrenaline spray (EURneffy) is now available and can be used to treat young children with anaphylaxis. 🚨 This article is open to all for a limited time — register for more MIMS content every month. Read more on MIMS buff.ly/VJiz1F6

The breath-actuated dry powder inhaler Ventolin Accuhaler (salbutamol) is out of stock, with resupply expected in early November. Read more on MIMS buff.ly/rQgRcdk

The MHRA is introducing new measures to improve communication of key risks associated with antidepressants, including suicide and sexual dysfunction, following a major review. Read more on MIMS buff.ly/6Ocvhzz

A once-weekly insulin (efsitora alfa) has received MHRA approval for the treatment of type II diabetes after NICE provisionally recommended it in August. Read more on MIMS buff.ly/Alrwd9o

This week's #drugshortages ➡️ Elvanse 60mg and 70mg capsules (lisdexamfetamine) ➡️ Levosert (levonorgestrel) ➡️ Malarone (atovaquone/proguanil) For more information, see the MIMS Drug Shortages tracker buff.ly/eomPhgc

Addepta XL (methylphenidate) is now available for the treatment of ADHD in children aged six to 17 years. 🚨 This article is open to all for a limited time — register for more MIMS content every month. Read more on MIMS buff.ly/7VTrgUA

#MIMSLearningLive North will open its doors in Liverpool on Friday 6 November 2026, giving you access to tailored learning that will inspire you to achieve even better outcomes for your patients. #MIMSHealthcareNetwork Read more on MIMS buff.ly/UyksRfJ

GLP-1 medications can affect the absorption of drugs with a narrow therapeutic window, such as digoxin, clinical pharmacist Murtada Hassan reminds prescribers. Read more on MIMS buff.ly/yZeCUxu

This week's #drugshortages ➡️ Adartrel 250 microgram tablets (ropinirole) ➡️ Imigran Radis 50mg tablets (sumatriptan) ➡️ Inegy 10mg/20mg tablets (ezetimibe/simvastatin) For more information, see the MIMS Drug Shortages tracker buff.ly/XOVPufJ

Lacidipine 2mg and 4mg tablets are out of stock until early November 2026, and this shortage coincides with a record number of price concessions being reported. Read more on MIMS buff.ly/1fRCgie

Patients on new obesity drug lose up to a quarter of body weight in late-stage trial buff.ly/p7M2RNM ✨️ 📖 This article is open to all for a limited time 📖 ✨️ - register for more MIMS content every month.

A National Patient Safety Alert has been issued for the upcoming discontinuation of Levemir buff.ly/liBj3f2

A new quick-reference MIMS table provides healthcare professionals with key information on digital technologies for asthma and COPD that can be used within the NHS buff.ly/lqFm1pO

COVID vaccine options updated as autumn vaccination programme begins. Read more on MIMS: buff.ly/D1ExhZb

This week's new #drugshortages ➡️ Dostinex (cabergoline) ➡️ Imigran Subject refill pack (sumatriptan) ➡️ Malarone (atovaquone/proguanil) For more information, see the MIMS Drug Shortages Tracker buff.ly/IxGZqmw

Atorvastatin is now available in a combination tablet with ezetimibe buff.ly/f1xReyB

There are advantages and disadvantages of weight loss drugs compared with injections, and choosing which one to use will ‘come down to a discussion between the doctor and the patient’, according to obesity specialist Prof John Wilding Read more on MIMS buff.ly/TjAdEA1

Anticonvulsant selection is associated with distinct risks in adults with epilepsy taking direct oral anticoagulants, according to a retrospective cohort study. Read more on MIMS buff.ly/VsSgSCJ